𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A model of prostatic carcinoma tumor kinetics based on prostate specific antigen levels after radiation therapy

✍ Scribed by Irving D. Kaplan; Richard S. Cox; Malcolm A. Bagshaw


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
496 KB
Volume
68
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The fall and rise of prostate-specific a
✍ Gunar K. Zagars; Alan Pollack πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 890 KB

Background. The serum kinetics of prostate-specific antigen (PSA) after radiation therapy for prostate cancer are not well characterized, and the potential prognostic significance of serum half-lives and of serum doubling times is unclear. This study was designed to address those issues. Methods. O

Rosiglitazone versus placebo for men wit
✍ Matthew R. Smith; Judith Manola; Donald S. Kaufman; Daniel George; William K. Oh πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 88 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The objective of this study was to assess the biologic activity of rosiglitazone, a peroxisome proliferator‐activated receptor Ξ³ agonist that has been approved to treat type 2 diabetes, in men with recurrent prostate carcinoma using change in prostate specific antigen (PS

The correlation of serial prostate speci
✍ Frank A. Vicini; Larry L. Kestin; Alvaro A. Martinez πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 133 KB πŸ‘ 2 views

## Background: The authors analyzed retrospectively their institution's experience in treating patients with localized prostate carcinoma with external beam radiation therapy (ebrt) to determine the correlation of various biochemical failure (bf) definitions with clinical failure and cause specific

Evaluation of radiation effect, tumor di
✍ Juanita M. Crook; Yasir A. Bahadur; Susan J. Robertson; Gad A. Perry; Bernd A. E πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 249 KB πŸ‘ 2 views

tients with residual tumor in 1 or more biopsies at 10 -78 months of follow-up Regional Cancer Centre, Ottawa, Ontario, Canwere selected for review. All patients had undergone biopsy on more than one ada. occasion. The 198 biopsies were stained for PSA, high molecular weight keratin,

Validation of a treatment policy for pat
✍ Wayne H. Pinover; Eric M. Horwitz; Alexandra L. Hanlon; Robert G. Uzzo; Gerald E πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 107 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The objective of this report was to present an outcomes validation for the Fox Chase Cancer Center (FCCC) management policy for patients who demonstrate prostate specific antigen (PSA) failure after receiving three‐dimensional conformal radiation therapy (3DCRT). ## METH